Investment Pitches

Pitch Summary:
Israel-based provider of products for information technology security, Check Point Software Technologies Ltd. also traded lower during the period despite robust earnings, highlighted by a significant beat in product revenues and double-digit billings growth. Consumers are adopting more pillars of Check Point’s platform and engaging in larger strategic commitments with Infinity and Quantum Force. Meanwhile, new CEO Nadav Zafrir, expanded the executive team to balance corporate and go-to-market leadership roles as well as bring more attention to customer facing functions. Check Point continues to be an astute steward of capital, pursuing organic growth and utilizing surplus cash to return capital to shareholders. We also like the company’s exposure to the fast-growing cloud security market and its industry leading profitability.

BSD Analysis:
Check Point is the cybersecurity veteran that keeps outperforming because it doesn’t chase hype — it delivers protection that actually works. The company has quietly rebuilt its product suite around next-gen firewalls, cloud security, and AI-powered threat detection. Gross margins are elite, FCF is massive, and Check Point’s conservative culture means no blowups, just steady compounding. In a chaotic cybersecurity market, consistency is a weapon — and Check Point has it.

Pitch Summary:
New holding, Lasertec Corporation, which is a Japan-based niche manufacturer of semiconductor and flat panel display production equipment, was a top contributor over the period. A recent pullback in the stock following order cuts, product inspection delays and concerns about the threat of new competitors provided an attractive entry point. Following our initiation, improving investor sentiment lifted shares as Lasertec remains the only company with commercialized inspection systems that use extreme ultraviolet lithography (EUV) light sources. Management also reiterated their expectation for an order recovery in 2026 with the number of specific projects increasing and visibility in the outlook improving. Moreover, we believe Lasertec’s process control intensity is nearing an inflection as the business shifts towards high volume manufacturing. Notably, the company’s actinic patterned mask inspection (APMI) tool also provides a cheaper alternative to advanced semiconductor materials lithography (ASML). We think this in combination with an expansion of EUV processes in semiconductor production offers significant upside over the long-term.

BSD Analysis:
Lasertec doesn’t compete — it dictates the rules. EUV pellicle inspection, mask defect detection, reticle qualification: every advanced-node wafer touches Lasertec’s value chain. As fabs push to 2nm and beyond, inspection steps proliferate, not shrink. The company’s growth is tied directly to advanced-node complexity, which is literally exponential. This is a premium equipment supplier with a near-monopolistic moat.

Pitch Summary:
We bought Spain-based global commercial bank Banco Bilbao Vizcaya Argentaria SA (BBVA) which operates the largest bank in Mexico and has leading franchises across South America and Turkey. We expect loan growth in Mexico to be driven by market share gains, low levels of leverage and the potential near shoring of US production. We also favor BBVA’s exposure to Turkey and its attractive age demographics. Falling inflation and a reduction in the policy rate in the country should help revenues prosper. A potential merger between BBVA and Banco Sabadell would also unlock significant value via market share gains, cost synergies and scale in product offerings as well as technological investments. Even though BBVA offers a superior return-on-equity relative to peers, at current levels shares are trading at a meaningful discount.

BSD Analysis:
BBVA is one of Europe’s most mispriced banks — a capital-rich, high-ROE franchise with massive exposure to Mexico’s structural growth, where credit demand is booming. NII is strong, credit quality stable, and digitization keeps pushing efficiency higher. Europe adds ballast; Mexico adds torque. Despite strong profitability and capital returns, the stock still trades at a deep discount because the market can’t let go of outdated risk stereotypes. This is a stealth compounder masquerading as an emerging-market bank.

Pitch Summary:
New holding, Lasertec Corporation, which is a Japan-based niche manufacturer of semiconductor and flat panel display production equipment, was another top contributor over the period. A recent pullback in the stock following order cuts, product inspection delays and concerns about the threat of new competitors provided an attractive entry point. Following our initiation, improving investor sentiment lifted shares as Lasertec remains the only company with commercialized inspection systems that use extreme ultraviolet lithography (EUV) light sources. Management also reiterated their expectation for an order recovery in 2026 with the number of specific projects increasing and visibility in the outlook improving. Moreover, we believe Lasertec’s process control intensity is nearing an inflection as the business shifts towards high volume manufacturing. Notably, the company’s actinic patterned mask inspection (APMI) tool also provides a cheaper alternative to advanced semiconductor materials lithography (ASML). We think this in combination with an expansion of EUV processes in semiconductor production offers significant upside over the long-term.

BSD Analysis:
Lasertec owns the mask inspection niche at the bleeding edge of EUV manufacturing — a bottleneck that’s only getting more critical as error tolerances shrink. Its tools are essential for every major foundry, and orders keep climbing alongside advanced-node complexity. Margins are huge, backlog is heavy, and Lasertec’s tech advantage is measured in years, not quarters. If AI and HBM keep exploding, Lasertec’s inspection empire becomes even more indispensable.

Pitch Summary:
Bio-Techne is a leading provider of essential life science products, including reagents (such as proteins), analytical instruments, and related services. Its products are primarily used by customers in biopharmaceutical companies, academic and government research institutions, and clinical laboratories to support drug development, advanced scientific research, and innovative diagnostic techniques. Shares of Bio-Techne detracted from performance in the second quarter after the company delivered solid fiscal third-quarter results but lowered its guidance for the fiscal fourth quarter, citing challenging macroeconomic conditions. Management highlighted near-term concerns related to uncertainty over global tariffs, constraints on academic research funding, and pressures on drug pricing, all of which could temporarily weaken demand. However, despite these short-term challenges, we maintain a favorable view of the company’s long-term fundamentals, driven by its innovative product portfolio, experienced management team, and strong underlying business model.

BSD Analysis:
Bio-Techne is the research-tools powerhouse quietly embedded in every corner of biotech, proteomics, and cell therapy. Its reagents, proteins, and instruments are high-margin, high-recurrence products that labs can’t easily switch away from. Growth slowed with the biotech funding downturn, but Bio-Techne’s product breadth and innovation pipeline give it leverage once capital flows normalize. The company is diversified across diagnostics, life sciences, and bioprocessing, providing stability in volatile cycles. Bio-Techne isn’t a hype-driven biotech — it’s the picks-and-shovels supplier with structural demand. When R&D spending rebounds, margins and revenue should re-accelerate sharply.

Pitch Summary:
Neogen develops, manufactures, and markets a diverse range of products dedicated to food and animal safety. Its Food Safety segment includes diagnostic test kits and related products used by food producers and processors to detect harmful or unintended substances in human food and animal feed. Its Animal Safety segment provides pharmaceuticals, vaccines, veterinary instruments, disinfectants, diagnostic products, rodenticides, and genomic testing services. Shares detracted from performance during the quarter after the company reported fiscal third-quarter revenue and profitability below expectations. Additionally, management modestly lowered its full-year 2025 guidance, citing a weaker macroeconomic environment impacting food production volumes and the strategic decision to exit non-core areas within its animal genomics business.

BSD Analysis:
Neogen is a food and animal safety platform riding secular growth in global biosecurity — a trend that’s not slowing. The integration of the 3M food safety business gives it scale, cross-sell power, and a broader product suite. Margins are improving, operating leverage is building, and Neogen’s recurring consumables revenue is sticky. Global regulations around testing, traceability, and contamination play directly into Neogen’s hands. The company is still digesting acquisitions, but the long-term picture is a cleaner, stronger, more defensible business. The stock trades like a slow grower, but the fundamentals say otherwise.

Pitch Summary:
Federal Signal Corporation, founded in 1901, manufactures a wide range of products and solutions used by municipal, government, industrial, and commercial customers. Its product line includes equipment such as sewer cleaners, industrial vacuum loaders, trucks for vacuum and hydro-excavation, street sweepers, road marking and line removal tools, water blasting equipment, dump truck bodies, trailers, and safety systems designed for public safety markets. Additionally, Federal Signal provides aftermarket services, including parts, repairs, equipment rentals, and training. Shares contributed positively during the quarter after reporting better-than-expected fiscal first-quarter operating results, where revenues and earnings beat consensus estimates. These strong results demonstrated continued demand and robust growth in customer orders, reflected by a higher ratio of new orders to completed sales compared to the previous quarter. Management also reaffirmed its revenue outlook for fiscal year 2025 and slightly increased its guidance for earnings per share.

BSD Analysis:
Federal Signal makes the specialty trucks and safety equipment cities literally can’t function without — sewer cleaners, industrial vacs, fire & safety gear. Municipal budgets are healthy, infrastructure spending is strong, and Federal Signal’s order book reflects a multi-year demand run. Margins are expanding as mix shifts toward higher-spec equipment with fewer direct competitors. The company’s balance sheet is clean, acquisitions are accretive, and recurring service revenue adds stability. This is a steady compounder disguised as a boring industrial. The upside comes from consistency — not hype cycles.

Pitch Summary:
RBC Bearings is a leading manufacturer of precision-engineered bearings—components essential for many types of machines, aircraft, and mechanical systems. These bearings help reduce wear on moving parts, improve power transfer, minimize friction-related damage, and efficiently manage pressure and flow within equipment. RBC specializes in creating highly technical bearings for markets requiring advanced design, testing, and manufacturing skills, such as aerospace, defense, and industrial sectors. We believe the company has a strong competitive advantage, often being the sole provider of specific bearing products. During the quarter, shares contributed positively to performance driven by a combination of increasing production rates from major aircraft manufacturers, strong demand from commercial aerospace maintenance markets, higher defense spending, and improving conditions in general industrial markets.

BSD Analysis:
RBC Bearings is the precision-components powerhouse hiding in plain sight — supplying aerospace, defense, and industrial markets with mission-critical parts competitors can’t easily replicate. Aerospace build rates are ramping, defense spending is rising, and RBC’s content per aircraft is expanding. The Dodge acquisition created a diversified cash engine that stabilizes earnings even during aero cycles. Margins are elite, pricing power is real, and the company’s engineering moat keeps widening. This is a quiet compounder that the market rarely appreciates until the numbers force the issue.

Pitch Summary:
Tutor Perini Corporation is a leading construction company providing a broad range of general contracting, construction management, and design-build services to private and public-sector clients globally. Tutor Perini’s offerings include comprehensive project management—from pre-construction planning to detailed scheduling of labor, equipment, materials, and subcontractors—as well as self-performed construction services such as site preparation, concrete forming and placement, steel erection, electrical work, mechanical systems, plumbing, HVAC (heating, ventilation, and air conditioning), and fire protection. Shares of Tutor Perini contributed positively during the quarter after the company reported strong first-quarter financial results and increased its full-year 2025 earnings guidance. Additionally, management reiterated its expectation that company earnings could double in 2026 from 2025 levels, supported by robust infrastructure spending and improved operational execution, resulting in higher profit margins.

BSD Analysis:
Tutor Perini is the construction contractor investors gave up on — and that capitulation has created massive mispricing. Government backlog is enormous, megaproject awards are rising, and the company is finally collecting cash on old claims that crushed sentiment for years. The balance sheet is improving, the margin outlook is stabilizing, and Tutor Perini is positioned to win in a multiyear public-infrastructure boom. Execution risk is real, but the upside if workflows normalize is huge given the depressed valuation. When the market finally believes the turnaround, this stock will re-rate violently.

Pitch Summary:
Ryan Specialty Holdings is a leading provider of specialty insurance products and services, acting as a broker between insurance agents, brokers, and carriers. During the quarter, shares detracted from performance due to lower property insurance pricing across the industry, which negatively impacted the company's premium volumes. However, we view this challenge as temporary and continue to believe Ryan Specialty has the potential to grow earnings faster than the overall market through favorable pricing, higher business volumes, and strategic acquisitions.

BSD Analysis:
Ryan Specialty is the E&S insurance machine eating market share while the big carriers struggle with underwriting discipline. Specialty pricing power is strong, loss ratios are stable, and Ryan’s delegated authority model gives it scale advantages most MGAs can’t replicate. The company’s distribution platform and broker ecosystem create fees and commissions with minimal balance sheet risk. Cash flow is predictable, and the long runway of E&S expansion is only getting started. The stock trades at a premium for a reason — but even that premium undervalues the structural growth story here. Ryan is what modern specialty insurance leadership looks like.

Pitch Summary:
Clearwater Analytics is a leading provider of cloud-based investment analytics and reporting solutions, primarily serving insurance companies, institutional investors, and corporate clients. During the quarter, Clearwater made several acquisitions, aiming to enhance its platform into a comprehensive, end-to-end investment management solution. However, shares detracted from performance due to market concerns that the debt incurred to finance these acquisitions increased the company’s risk profile, as well as potential integration risks associated with managing multiple acquisitions simultaneously. In our view, these acquisitions have the potential to be transformational, significantly expanding Clearwater’s total addressable market and strengthening its competitive position. Further, we consider the elevated debt levels and integration risks temporary. Although investor apprehension surrounding these acquisitions led to share price weakness this quarter, we recognize management’s rationale that these strategic moves were essential to broaden the product offering and support longer-term growth. Furthermore, the company continues to deliver strong financial results and provided robust guidance for the fiscal year.

BSD Analysis:
Clearwater Analytics runs the back-office data pipes for asset managers and insurers — and once they integrate Clearwater, they never leave. The company’s sticky SaaS model, integrated workflows, and real-time data capabilities give it an edge that manual processes can’t touch. Growth is consistent, margins are expanding, and international adoption is just beginning. The capital-light model turns every incremental customer into high-quality recurring revenue. Clearwater’s role in regulatory reporting and investment accounting gives it deep integration across finance departments. This isn’t an accounting tool — it’s mission-critical infrastructure built for the next generation of asset management.

Pitch Summary:
Vertiv specializes in critical cooling and power management infrastructure technologies, catering primarily to data center clients. As an industry leader in data center power and cooling solutions, we believe Vertiv is well-positioned to benefit from long-term growth driven by increasing demand for AI and computing capabilities. During the quarter, shares contributed positively to performance after the company delivered strong first-quarter results, where revenues and earnings both exceeded analyst estimates driven by rising demand from AI-enabled data centers. Investor optimism was further fueled by upbeat guidance, with management raising full-year revenue estimates and signaling continued AI-driven growth in orders and backlog.

BSD Analysis:
Vertiv is the infrastructure arms dealer of the AI datacenter boom — thermal, power, racks, you name it. Its blowout margins prove hyperscalers are desperate for capacity, and Vertiv’s scale means it can deliver while smaller peers drown in backlog. Execution has tightened dramatically after years of inconsistency, turning Vertiv into one of the highest-torque AI beneficiaries in industrials. Cash flow is surging, pricing power is real, and demand visibility stretches years ahead. The market still underrates how central cooling and power management are to AI deployments. Vertiv is no longer a turnaround — it’s a compounder directly plugged into the AI megacycle.

Pitch Summary:
Cloudflare provides cloud-based security, performance optimization, and reliability solutions designed to enhance the speed, safety, and resilience of internet applications and websites worldwide. Its products include content delivery networks, website protection, and application performance services, as well as advanced developer tools that support building and deploying web applications. We believe the company is benefiting from several favorable product cycles, robust sales execution, and an exceptional management team. In our view, the company is well-positioned to capitalize on key industry trends, including edge-based AI, secure access service edge (SASE), edge security solutions, and zero trust network access. Shares contributed positively during the quarter following strong fiscal first-quarter results that exceeded analyst estimates. Better-than-expected revenues were driven by increased demand for subscription services and heightened adoption of its developer platform, Workers, and SASE offerings. Additionally, investor optimism was fueled by Cloudflare securing a significant new contract exceeding $100 million, highlighting the growing importance and scale of its platform. Management also reaffirmed robust full-year revenue guidance, signaling confidence in continued growth and strategic execution.

BSD Analysis:
Cloudflare is building the internet’s control plane in real time, and competitors can’t catch up without burning billions. Its global network gives it an edge in security, CDN, edge compute, and zero-trust that keeps strengthening as traffic grows. Revenue growth is re-accelerating, margins are improving, and R2 + Workers are quietly becoming the developer platform of choice for modern web infrastructure. Cloudflare doesn’t need to be the biggest — it just needs to keep being the fastest and easiest to build on, which it is. Enterprise adoption is spreading deeper into mission-critical workloads, and the company’s innovation velocity is absurd. This isn’t a CDN story anymore — it’s a next-gen cloud platform masquerading as one.

Pitch Summary:
Palantir Technologies is a leading provider of data analytics software designed to integrate and analyze large, complex datasets for government agencies and commercial enterprises globally. Its platforms, such as Gotham and Foundry, enable users to rapidly visualize and interpret critical data to inform high-impact decisions across defense, intelligence, and corporate sectors. The company has benefitted from its ability to consistently expand revenues in both its Government and Commercial segments, driven by growing adoption of AI solutions and increasing government spending on defense and intelligence capabilities. During the quarter, Palantir shares rose significantly supported by strong fiscal first-quarter results featuring 39% year-over-year revenue growth, driven by robust increases in U.S. commercial and government contracts. Management also raised full-year revenue guidance, citing increased demand for AI-driven solutions and the positive impact of rising defense expenditures.

BSD Analysis:
Palantir is the AI defense contractor masquerading as a software company — and its U.S. government moat is becoming more valuable by the quarter. The company’s AI Platform (AIP) is exploding in commercial adoption thanks to its ability to deploy real AI workflows, not slide-deck fantasies. Government work remains sticky, high-margin, and expanding as geopolitical tension rises. Palantir’s operating discipline has improved dramatically, turning it from a money-burning enigma into a real FCF generator. The stock still gets hated for valuation, but Palantir is one of the few enterprise AI vendors selling tools that actually do something in production. This is a misunderstood AI infrastructure play with years of runway.

Pitch Summary:
JPMorgan is the stealth winner of the emerging regulated stablecoin era. With the launch of its JPMD deposit token on Coinbase’s Base network, JPM is positioned to dominate blockchain-based payments under the new GENIUS Act, which effectively hands the stablecoin market to the largest U.S. banks. JPMD allows 24/7 settlement of tokenized deposits backed by Treasuries—creating a new, zero-interest funding source that enhances JPM’s net interest margin and reduces compliance costs through on-chain automation. The combination of balance sheet relief, freed-up capital from SLR reforms, and $6–7T in potential stablecoin-linked T-bill demand could drive a step-change in EPS and ROE.

BSD Analysis:
JPMorgan’s leadership in blockchain finance gives it a structural edge as stablecoins transition from FinTech innovation to bank-dominated infrastructure. The GENIUS Act locks non-banks out of large-scale issuance, enabling JPM and peers to capture the stablecoin deposit base while earning Fed Funds yield on underlying Treasuries—without paying interest to holders. At the same time, AI-driven compliance automation and blockchain transparency could cut industry-wide regulatory costs ($20B+) and materially improve efficiency ratios. With a first-mover advantage, 24/7 programmable payments, and growing institutional demand, JPM could see incremental NIM expansion and capital leverage as stablecoins scale toward $2T globally. The market has yet to price in the earnings uplift from this new, regulated digital deposit layer.

Pitch Summary:
Mister Car Wash is the dominant player in a fragmented U.S. car-wash market, operating over 500 locations with 2.2 million subscription members in its Unlimited Wash Club (UWC). The business blends strong recurring revenue, low-ticket repeat use, and high reinvestment returns (~25–30% IRR per new unit). The recent private-equity overbuild in express washes has reversed, restoring rational competition and pricing power. At ~10× owner earnings and ~11% FCF yield, MCW offers a defensive, cash-generative “boring compounder” with durable consumer habits, high incremental margins, and a long runway for disciplined growth.

BSD Analysis:
MCW’s model transforms a low-friction consumer habit into a high-return subscription service. Roughly 73% of wash revenue now comes from members, whose predictable monthly payments underpin steady cash flows and margin expansion. With the “Titanium” tier lifting average ticket 10% and same-store sales up 6%, Mister Car Wash is driving mix-led growth without heavy promotions or macro leverage. The fading PE-driven saturation, exit of weaker rivals (e.g., Zips bankruptcy), and rationalized new builds set the stage for normalized comps and improved pricing. Each new $2 mm net investment yields ~$700k unlevered FCF (35–40% COC), recycling into steady expansion via sale-leasebacks. Trading at ~10× owner earnings, MCW offers a clear path to mid-teens annualized returns through reinvested cash flow, incremental unit growth, and moderate multiple expansion as supply pressures ease.

Pitch Summary:
JPMorgan is the stealth winner of the emerging regulated stablecoin era. With the launch of its JPMD deposit token on Coinbase’s Base network, JPM is positioned to dominate blockchain-based payments under the new GENIUS Act, which effectively hands the stablecoin market to the largest U.S. banks. JPMD allows 24/7 settlement of tokenized deposits backed by Treasuries—creating a new, zero-interest funding source that enhances JPM’s net interest margin and reduces compliance costs through on-chain automation. The combination of balance sheet relief, freed-up capital from SLR reforms, and $6–7T in potential stablecoin-linked T-bill demand could drive a step-change in EPS and ROE.

BSD Analysis:
JPMorgan’s leadership in blockchain finance gives it a structural edge as stablecoins transition from FinTech innovation to bank-dominated infrastructure. The GENIUS Act locks non-banks out of large-scale issuance, enabling JPM and peers to capture the stablecoin deposit base while earning Fed Funds yield on underlying Treasuries—without paying interest to holders. At the same time, AI-driven compliance automation and blockchain transparency could cut industry-wide regulatory costs ($20B+) and materially improve efficiency ratios. With a first-mover advantage, 24/7 programmable payments, and growing institutional demand, JPM could see incremental NIM expansion and capital leverage as stablecoins scale toward $2T globally. The market has yet to price in the earnings uplift from this new, regulated digital deposit layer.

Pitch Summary:
The author is skeptical about Verve Therapeutics' potential to become a blockbuster due to the challenges of convincing stakeholders about the safety and efficacy of gene therapy for lowering LDL-C, especially when compared to existing treatments.

BSD Analysis:
The author highlights the competitive landscape with existing treatments like Merck's oral drug and Inclisiran, which have shown significant LDL-C reduction. Despite Verve's gene therapy offering a convenience benefit, the risks associated with gene therapy and the well-serviced nature of the indication make it a tough commercial story. The acquisition by Eli Lilly (LLY) suggests a differing view, with LLY betting on the efficacy data and potential of Verve's program. The author acknowledges the competitive efficacy data but remains cautious due to safety concerns and the historical unpopularity of the stock. The potential payout from a contingent value right (CVR) is seen as undervalued, but the author is willing to accept the illiquidity and risk for a likely payout.

Pitch Summary:
Long idea: JPM is positioned to be a stealth beneficiary of the stablecoin boom, offering exposure to blockchain-based deposits without paying up for speculative pure plays like Circle. In June 2025, JPM launched JPMD, a “deposit token” on Coinbase’s Base L2, giving it first-mover advantage among U.S. banks. Unlike 1:1 asset-backed stablecoins, JPMD represents commercial bank deposits under fractional banking rules, allowing JPM to both re-leverage deposits and capture NIM by buying T-bills. The newly passed GENIUS Act provides a protective moat by mandating bank-issued stablecoins, barring tech companies, and prohibiting interest payments to token holders, cementing an oligopoly. Stablecoins already process >$35T annually, more than Visa + Mastercard combined, with far lower costs; Treasury expects the market to 8× to $2T by 2035. JPM can capture flows via 24/7 settlement, expand its $2B/day blockchain rails (Kinexys), and reduce compliance costs (estimated $20B industry-wide) via AI + blockchain transparency. Combined with Fed capital relief on Treasuries, JPM has $5.5T more balance sheet capacity to lever deposits into T-bills. Author argues TBTF banks as a group could see equity upside of +180% from stablecoins alone, with JPM a key beneficiary. At ~15× earnings, JPM offers exposure to a regulated, bank-friendly monopoly on digital dollars, paired with traditional bank earnings growth.

BSD Analysis:
Very non-consensus thesis: that stablecoins shift from fintechs to TBTF banks, creating both margin expansion (no yield to depositors, leveraged into T-bills) and cost compression (AI-driven compliance). JPM is uniquely positioned with scale, infrastructure, and first-mover advantage. Risks: stablecoin adoption curve, political/regulatory shifts, and execution on customer conversion. Still, thesis is asymmetric: even partial adoption could drive significant incremental EPS/ROE. This is an unusual blend of fintech disruption narrative with a value-bank multiple, a contrarian long.

Pitch Summary:
Largest U.S. car-wash operator (518 sites) with ~2.2M subscription members (UWC), benefiting from brand density, convenience, and scale in a fragmented category. The PE-fuelled overbuild (2021–23) is abating—competitors are slowing, closing, or restructuring—easing promos and restoring pricing power. MCW kept a measured 35–40/yr new-unit pace and still sees unit-level cash returns of ~35–40% and mid-20s IRRs after sale-leasebacks. Mix and membership are key: 73% of wash revenue is from subscribers; the new Titanium tier hit ~23% penetration and lifted Rev/Member ~10%, with a base-plan +$3 price action and Q1’25 comps of +6%. Incremental washes carry very high drop-through (chemicals/utilities ≈$1.50/car), so modest throughput or mix gains move SSS and margins. Greenfield projects net ~$1.8–2.0M after SLB on ~$6M gross build, with modular, labor-light ops (2–4 staff/shift). Tech/ops stack (LPR, centralized maintenance, chemistry) plus early robotics optionality offer small but compounding cost wins at 500+ sites. LTM OCF ≈$278M; minus ~$55M maint capex implies “owner earnings” ≈$223M (~10–11% yield vs. ~$2.1B mkt cap). Balance sheet: net debt ≈$820M; SLBs fund growth while holding leverage steady. Controlled by Leonard Green; governance overhang exists, but playbook continuity is also a strength.

BSD Analysis:
Quality compounding setup: high recurring revenue, sticky behavior, and attractive reinvestment at scale, bought around ~10× “owner earnings.” The supply-glut hangover is turning to a tailwind as weaker PE builds pull back, supporting price/mix and new-site selection. Key debates: saturation risk in certain Sunbelt markets, SLB sensitivity to higher cap rates, and sponsor control/overhang. Still, MCW’s measured growth, dense networks, and subscription flywheel make mid-teens IRRs plausible without heroic assumptions; downside cushioned by cash generation and the ability to throttle growth.